Telbivudine therapy for chronic hepatitis B: A journey to identify super-responders and to optimize treatment using the roadmap model-Reference-Cited by-同舟云学术

Telbivudine therapy for chronic hepatitis B: A journey to identify super-responders and to optimize treatment using the roadmap model

Published:2017-01 Issue:1 Volume:32 Page:73-81
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:Journal of Gastroenterology and Hepatology

Author:

Kao Jia-Horng¹,Asselah Tarik²,Dou Xiao-Guang³,Hamed Kamal⁴^ORCID

Affiliation:

1. Graduate Institute of Clinical Medicine and Hepatitis Research Center; National Taiwan University College of Medicine and Hospital; Taipei Taiwan

2. Hepatology Department, AP-HP, Beaujon Hospital; University Paris Diderot and INSERM UMR1149, Centre de Recherche sur l'inflammation, Labex INFLAMEX; Clichy France

3. Department of Infectious Disease; Shengjing Hospital, China Medical University; Shenyang China

4. Novartis Pharmaceuticals Corporation; East Hanover New Jersey USA

Funder

Novartis Pharma AG

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jgh.13512/fullpdf

Reference76 articles.

1. Natural killer cells in hepatitis B virus infection;Wu;Braz. J. Infect. Dis.,2015

2. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013;Schweitzer;Lancet,2015

3. National institutes of health consensus development conference statement: management of hepatitis B;Sorrell;Ann. Intern. Med.,2009

4. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level;Chen;JAMA,2006

5. Hepatitis B virus genotypes and variants;Lin;Cold Spring Harb Perspect. Med.,2015

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis B Virus and Hepatocellular Cancer: Molecular Mechanisms and Breakthroughs in Therapeutic Approaches;Pathogens Associated with the Development of Cancer in Humans;2024

2. Treatment Response to Oral Antivirals in Chronic Hepatitis B Patients: Assessment of Polymorphism in the IL-28B Gene (rs809991);Viral Hepatitis Journal;2023-12-26

3. Kinetics of hepatitis B surface antigen and estimated glomerular filtration rate in telbivudine-treated hepatitis B patients with different rescue strategies;PLOS ONE;2020-08-12

4. Baseline serum miR‑125b levels predict virologic response to nucleos(t)ide analogue treatment in patients with HBeAg‑positive chronic hepatitis B;Experimental and Therapeutic Medicine;2018-09-03

5. Considerations of antiviral treatment to interrupt mother-to-child transmission of hepatitis B virus in China;International Journal of Epidemiology;2018-05-10